Robotic Ultrasound-Guided Central Pancreatectomy with Main Pancreatic Duct Endoscopy Evaluation for High-Risk, Mixed-Type Intraductal Papillary Mucinous Neoplasm

被引:3
|
作者
Giuliani, Giuseppe [1 ]
Guerra, Francesco [1 ]
Matarazzo, Francesco [1 ]
De Franco, Lorenzo [1 ]
Di Marino, Michele [1 ]
Coratti, Andrea [1 ]
机构
[1] Misericordia Hosp, Scuola Chirurg Robot SCR, Dept Gen & Urgent Surg, Grosseto, Italy
关键词
D O I
10.1245/s10434-024-15231-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundCentral pancreatectomy (CP) is a parenchymal-sparing technique indicated for the resection of selected lesions of the neck or proximal body of the pancreas.1,2 The risk of postoperative complications is theoretically doubled because the surgeon has to manage two cut surfaces of the pancreas. The video shows a fully robotic CP to treat a 62-year-old male patient with a mixed-type intraductal papillary mucinous neoplasm (IPMN) of the pancreatic neck, using ultrasound (US) and Wirsung endoscopic evaluation to guide the pancreatic resection and ensure optimal resection margins.Materials and MethodsA US-guided robotic CP was carried out, and an intraoperative endoscopic evaluation of the MPD was performed to determine the distal transection level. A transmesocolic, end-to-side, robot-sewn Wirsung-jejunostomy with internal MPD stenting was then created. The procedure was completed with a side-to-side jejunojejunostomy.ResultsThe operative time was 290 min, with negligible blood loss. During the postoperative course, the patient experienced bleeding from a branch of the gastroduodenal artery with subsequent fluid collection, which was successfully treated with angioembolization and percutaneous drainage. He was discharged home on postoperative day 22. Final pathology revealed a non-invasive IPMN with low-grade dysplasia and free surgical margins. At 12 months of follow-up, the patient was doing well, with no evidence of local recurrence and endocrine or exocrine pancreatic insufficiency.ConclusionsThe combination of robotic surgery with intraoperative US and Wirsungoscopy may offer distinct technical advantages for challenging pancreatectomies that follow the principles of parenchymal-sparing surgery.
引用
收藏
页码:4634 / 4634
页数:1
相关论文
共 49 条
  • [21] Answer to: Image 6: Main Duct Type Intraductal Papillary Mucinous Neoplasm with High-Grade Dysplasia
    Kim, Sung Bum
    Lee, Dong Shik
    Choi, Joon Hyuk
    GASTROENTEROLOGY, 2020, 159 (03) : E13 - E15
  • [22] 3 Cases of Main Duct Type Intraductal Papillary-Mucinous Neoplasm Which Recurred in the Remnant Pancreas After the First Pancreatectomy
    Endo, A.
    Shimamura, H.
    Kanehara, K.
    Takeda, K.
    PANCREAS, 2014, 43 (08) : 1356 - 1356
  • [23] Main-duct Intraductal Papillary Mucinous Neoplasm. High Cancer Risk in Duct Diameter of 5 to 9 mm
    Del Chiaro, Marco
    Schulick, Richard D.
    ANNALS OF SURGERY, 2017, 266 (06) : E86 - E86
  • [24] The Use of Endoscopic Ultrasound in Differentiating Side Branch vs. Main Duct vs. Mixed Duct Intraductal Papillary Mucinous Neoplasm
    Harris, Cynthia L.
    Malafa, Mokenge P.
    Weber, Jill
    Klapman, Jason B.
    GASTROINTESTINAL ENDOSCOPY, 2010, 71 (05) : AB285 - AB285
  • [25] Segmental Versus Diffuse Main Duct Intraductal Papillary Mucinous Neoplasm Examination of Main Pancreatic Duct Morphology and Implications for Malignancy Risk and Extent of Surgical Resection
    Ecker, Brett L.
    Dickinson, Shannan M.
    Saadat, Lily V.
    Tao, Alice J.
    Pulvirenti, Alessandra
    Balachandran, Vinod P.
    D'Angelica, Michael I.
    Drebin, Jeffrey A.
    Kingham, T. P.
    Jarnagin, William R.
    Wei, Alice C.
    Gonen, Mithat
    Soares, Kevin C.
    ANNALS OF SURGERY, 2023, 278 (01) : 110 - 117
  • [26] SIZE AND SITE OF MAIN PANCREATIC DUCT DILATION CORRELATES WITH DISTINCT RISK OF MALIGNANCY IN MAIN- DUCT/ MIXED INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS OF THE PANCREAS
    Crippa, S.
    Aleotti, F.
    Belfiori, G.
    Longo, E.
    Di Salvo, F.
    Partelli, S.
    Balzano, G.
    De Cobelli, F.
    Arcidiacono, P. G.
    Rubini, C.
    Zamboni, G.
    Lena, Schiavo M.
    Doglioni, C.
    Falconi, M.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : S30 - S31
  • [27] Predictive Factors for the Metachronous Development of High-risk Lesions in the Remnant Pancreas After Partial Pancreatectomy for Intraductal Papillary Mucinous Neoplasm
    Miyasaka, Yoshihiro
    Ohtsuka, Takao
    Tamura, Koji
    Mori, Yasuhisa
    Shindo, Koji
    Yamada, Daisuke
    Takahata, Shunichi
    Ishigami, Kousei
    Ito, Tetsuhide
    Tokunaga, Shoji
    Oda, Yoshinao
    Mizumoto, Kazuhiro
    Nakamura, Masafumi
    Tanaka, Masao
    ANNALS OF SURGERY, 2016, 263 (06) : 1180 - 1187
  • [28] Surgical Decisions Based on a Balance between Malignancy Probability and Surgical Risk in Patients with Branch and Mixed-Type Intraductal Papillary Mucinous Neoplasm
    Lee, Seung Jae
    Park, Seo Young
    Hwang, Dae Wook
    Lee, Jae Hoon
    Song, Ki Byung
    Lee, Woohyung
    Kwon, Jaewoo
    Park, Yejong
    Kim, Song Cheol
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09) : 1 - 12
  • [29] Evaluation of the Prognostic Significance of 'High-risk Stigmata' in the International Consensus Guidelines 2012 for Intraductal Papillary Mucinous Neoplasm
    Kimura, K.
    Amano, R.
    Yamazoe, S.
    Ohira, G.
    Miura, K.
    Nishio, K.
    Sakurai, K.
    Toyokawa, T.
    Ohira, M.
    Hirakawa, K.
    PANCREAS, 2015, 44 (08) : 1387 - 1387
  • [30] Enhancing Mural Nodules in the Main Pancreatic Duct of Main and Mixed Types of Intraductal Papillary Mucinous Neoplasms: Does Size Matter in Malignancy Risk?
    Chon, Hyung Ku
    Song, Tae Jun
    Yoo, Kyoung-Hoon
    Hwang, Jun Seong
    Kim, Myung-Hwan
    Choi, Eun Kwang
    Kim, Tae Hyeon
    GUT AND LIVER, 2023, 17 (06) : 942 - 948